Tetracycline-Inducible Expression Systems Using CG-Free CMV Promoters
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing inducible expression systems using the tet operon in bacteria face limitations in transcriptional efficiency due to CG motifs, particularly in human CMV promoters, which can reduce expression levels and responsiveness to inducing agents.
Innovation Solution
A hybrid mouse-human CMV promoter is developed, lacking the CG motif at positions 42 and 43, combined with tet-operators and a tet-repressor or cumate repressor system, to enhance transcriptional control and responsiveness to tetracycline or cumate, respectively, using a piggyBac-like transposon for integration into mammalian cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If a human CMV promoter is used in an inducible expression system, then strong constitutive expression is achieved, but CG motifs reduce transcriptional efficiency and responsiveness to inducing agents
Solution Approach 1:
The patent removes the problematic CG motif at positions 42-43 from the human CMV promoter sequence while retaining the overall promoter structure and strength, thereby eliminating the factor that reduced transcriptional efficiency and responsiveness
Solution Approach 2:
The patent creates a hybrid promoter where only specific local regions are modified (the CG motif removal) while other regions maintain their original sequences, allowing localized optimization without compromising overall promoter function
2Reliability
If the tet-repressor binds strongly to tet-operators to inhibit expression, then tight control is achieved, but responsiveness to tetracycline induction is reduced
Solution Approach 1:
The patent modifies the tet-operator sequence to alter binding parameters of the tet-repressor, creating a balance where the repressor maintains sufficient binding affinity for tight control while allowing adequate responsiveness to tetracycline induction
3Productivity
If multiple CG motifs are present in the promoter region, then promoter strength is maintained, but methylation occurs reducing expression levels
Solution Approach 1:
The patent converts the harmful effect of CG motifs by selectively removing them, transforming a sequence feature that caused methylation and reduced expression into a beneficial absence that prevents methylation while maintaining promoter strength through other sequence elements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hybrid promoter system achieves higher expression levels, increased differential expression between on and off states, and greater responsiveness to inducing agents, enabling precise control of gene expression in mammalian cells.
Implementation Method 1
A hybrid mouse-human CMV promoter effective for transcriptional initiation
Implementation Method 2
The presence of tetracycline controls binding of the tet-repressor to the tet-operators
Implementation Method 3
greater responsiveness to inducing agents
Data Source
AI summary
The invention provides inducible promoter systems and their components incorporating components of a tetracycline operon. By coordinating expression of different transcriptional units in these systems as a result of selection of promoters and/or linking the units into the same DNA molecule, these systems can achieve higher levels of expression of coding segments of interest, increased differential levels of expression between on- and off-states, and/or greater responsiveness to inducing agents than conventional systems.